LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on the Graves’ disease market. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period to treat Graves’ disease.
This report by Technavio presents a detailed analysis of the market, including regulatory framework, drug development strategies, recruitment strategies, and key companies that are expected to play an essential role in the growth of the market in the coming years.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Graves’ disease: Market overview
Graves’ disease is an autoimmune disorder that causes the thyroid gland to produce excess thyroid hormone in the body. Graves’ disease occurs due to inheritance from either of the parent or any other autoimmune disorder. Some unknown type of infection in the body also causes Graves’ disease.
According to a senior market research analyst at Technavio, “Some of the common symptoms of Graves’ disease include goiter, weight loss, frequent bowel movement, trouble getting pregnant, and hair thinning.”
Graves’ disease: Segmentation analysis
This market research report segments the Graves’ disease market based on therapies employed that includes monotherapy and undisclosed, RoA (intradermal, intramuscular, intravenous, and undisclosed), therapeutic modalities (peptide, monoclonal antibody, small molecules, and undisclosed), targets for drugs under development (TSHR, thyroid stimulating antibodies, CD40 antigen, GPR174, and undisclosed), MoA (TSHR inhibitor, thyroid stimulating antibodies inhibitor, CD40 antigen inhibitor, and undisclosed), drugs under development (discovery, pre-clinical, phase I, and phase II), and recruitment status (completed, recruiting, and undisclosed). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Scope of the Report
Drug Development Landscape
- Drugs under development
- Indications coverage
Drug Development Strategies
- Therapies employed
- Therapeutic modality
- Geographical coverage
- Recruitment status
- Recruitment volume
- Type of players
- Company Overview
Discontinued or Dormant Molecules
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.